Skip to main content
Veterinary Medicines

CANIHELMIN PLUS

Suspended
  • Praziquantel
  • Pyrantel embonate
  • Febantel

Product identification

Medicine name:
CANIHELMIN PLUS
CANIHELMIN PLUS 50 mg/144mg/150mg COMPRIMIDOS PARA PERROS
Active substance:
  • Praziquantel
  • Pyrantel embonate
  • Febantel
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Praziquantel
    50.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    144.00
    milligram(s)
    /
    1.00
    Tablet
  • Febantel
    150.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Authorisation status:
  • Suspended
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Genera d.d.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera d.d.
Responsible authority:
  • The Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 3423 ESP
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0245/001
Concerned member states:
  • Bulgaria
  • Czechia
  • Romania

Documents

Summary of Product Characteristics

English (PDF)
Published on: 22/12/2023
Download
Spanish (PDF)
Published on: 27/02/2024

Package Leaflet

English (PDF)
Published on: 22/12/2023
Download
Spanish (PDF)
Published on: 27/02/2024

Labelling

English (PDF)
Published on: 22/12/2023
Download
Spanish (PDF)
Published on: 27/02/2024

Combined File of all Documents

English (PDF)
Published on: 21/11/2022
Download

eu-PUAR-esv0245001-dcp-canihelmin-plus-en.pdf

English (PDF)
Published on: 22/12/2023
Download

es-puar-canihelmin-plus-es.pdf

Spanish (PDF)
Published on: 17/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."